• April 24, 2024

Gellman to facilitate 22nd Century’s FDA applications

22nd Century Group, a leader in tobacco harm reduction, has appointed Gregg M. Gellman as the company’s director of business development and regulatory affairs. Gellman, who was hired for his experience in achieving U.S. Food and Drug Administration compliance approval for various types of products, will be tasked with driving 22nd Century’s regulatory affairs strategies for the company’s two modified risk cigarettes in development: “Brand A,” the world’s lowest nicotine tobacco cigarette, and “Brand B,” the world’s lowest tar-to-nicotine ratio cigarette.